Related Experiment Video
Updated: Aug 13, 2026

06:30
Rapid and Efficient Zebrafish Genotyping Using PCR with High-resolution Melt Analysis
Published on: February 5, 2014
Mutation scanning of the RET protooncogene using high-resolution melting analysis
Rebecca L Margraf1, Rong Mao, W Edward Highsmith
1Advanced Technology Group, ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT 84108, USA. rebecca.margraf@aruplab.com
Clinical Chemistry
|January 5, 2006
Summary
High-resolution amplicon melting analysis effectively detects RET protooncogene mutations, offering a sensitive alternative for diagnosing multiple endocrine neoplasia syndromes.
Area of Science:
- Genetics
- Molecular Biology
- Oncology
Background:
- Single-base pair missense mutations in specific RET protooncogene exons are linked to multiple endocrine neoplasia type 2 (MEN2) syndromes.
- Current RET mutation detection relies on exon sequencing, which can be time-consuming.
- MEN2A, MEN2B, and familial medullary thyroid carcinoma are associated with RET protooncogene mutations.
Purpose of the Study:
- To investigate the utility of high-resolution amplicon melting analysis for RET mutation detection.
- To establish a sensitive and efficient method for identifying RET protooncogene sequence variations.
Main Methods:
- High-resolution amplicon melting analysis was employed using LCGreen dye and the HR-1 melter.
- This technique detects heterozygous and homozygous sequence variations by analyzing amplicon melting curve shapes and positions.
- The assay was validated using samples with known RET mutations, polymorphisms, and wild-type genotypes.
Main Results:
- The developed assay successfully differentiated 26 unique RET mutations and 4 polymorphisms from the wild-type genotype.
- A blinded study confirmed 100% accuracy in distinguishing RET sequence variations from wild-type samples.
- Specific RET mutations were directly genotyped based on unique melting curve characteristics.
Conclusions:
- High-resolution amplicon melting analysis is a sensitive, closed-tube assay for detecting RET protooncogene sequence variations.
- This method provides an effective alternative for RET mutation scanning in the context of MEN2 syndromes.

